Which one of the following Indian institutes was approved by the Drugs Controller General of India for conducting human trials of the Oxford-AstraZeneca Covid-19 vaccine candidate?
Bharat Biotech
AIIMS
Serum Institute of India
National Institute of Epidemiology
Answer is Right!
Answer is Wrong!
This question was previously asked in
UPSC CDS-2 – 2020
The Serum Institute of India (SII), based in Pune, was approved by the Drugs Controller General of India (DCGI) to conduct phase 2 and 3 human clinical trials in India for the Oxford-AstraZeneca COVID-19 vaccine candidate, known as Covishield. SII had a partnership with AstraZeneca for the manufacturing and supply of the vaccine in India and globally.
– The question specifically asks about the Indian institute approved for *conducting human trials* of the Oxford-AstraZeneca vaccine candidate.
– Serum Institute of India was the primary partner in India for the manufacturing and trials of this specific vaccine.